March 3, 2022 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twenty-three patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON ap…
March 3, 2022 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON PEN Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN a…
